Medidata Solutions Inc. (NASDAQ:MDSO) had its target price boosted by Jefferies Group from $41.00 to $46.00 in a report published on Tuesday morning. They currently have an underperform rating on the stock.
“SYMC is to acquire LifeLock for $2.3B, combining antivirus and identity protection, while potentially returning the Consumer segment to growth. The company reiterated FY18 guide for $1.70-1.80 non-GAAP EPS, which we estimate could include $0.05 of LOCK accretion, offset by less-than-expected share repurchases. We believe the price of 3.7x Recurring Rev is reasonable given LOCK’s high rev retention and the strategic nature of the acquisition. Details. The $2.3B deal is expected to close in C1Q17/F4Q17, and will be financed using cash on hand and $750M in new debt.”,” Jefferies Group’s analyst commented.
Several other research analysts have also weighed in on MDSO. Morgan Stanley reiterated a buy rating and issued a $61.00 price objective on shares of Medidata Solutions in a research report on Thursday, August 25th. TheStreet upgraded Medidata Solutions from a hold rating to a buy rating in a research report on Thursday, August 25th. Deutsche Bank AG increased their price objective on Medidata Solutions from $56.00 to $58.00 and gave the stock a buy rating in a research report on Tuesday, September 13th. Finally, Zacks Investment Research upgraded Medidata Solutions from a hold rating to a buy rating and set a $54.00 price objective for the company in a research report on Tuesday, November 1st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company’s stock. Medidata Solutions has an average rating of Buy and a consensus price target of $54.80.
Medidata Solutions (NASDAQ:MDSO) opened at 55.74 on Tuesday. The stock has a 50 day moving average price of $51.55 and a 200 day moving average price of $50.53. The company has a market capitalization of $3.11 billion, a price-to-earnings ratio of 127.26 and a beta of 1.49. Medidata Solutions has a 52-week low of $30.22 and a 52-week high of $57.85.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Tuesday, October 25th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.02. The company earned $120.10 million during the quarter, compared to analyst estimates of $118.96 million. Medidata Solutions had a return on equity of 10.46% and a net margin of 5.70%. The firm’s revenue for the quarter was up 16.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.25 earnings per share. On average, equities analysts expect that Medidata Solutions will post $1.02 earnings per share for the current year.
In other Medidata Solutions news, EVP Michael I. Otner sold 7,331 shares of the firm’s stock in a transaction on Tuesday, October 25th. The stock was sold at an average price of $53.87, for a total value of $394,920.97. Following the sale, the executive vice president now directly owns 86,378 shares in the company, valued at $4,653,182.86. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Eileen Schloss sold 3,831 shares of the firm’s stock in a transaction on Wednesday, November 16th. The shares were sold at an average price of $56.60, for a total value of $216,834.60. Following the completion of the sale, the executive vice president now owns 33,561 shares in the company, valued at $1,899,552.60. The disclosure for this sale can be found here. 6.70% of the stock is owned by insiders.
Hedge funds have recently bought and sold shares of the stock. Parkwood LLC boosted its stake in Medidata Solutions by 3.1% in the third quarter. Parkwood LLC now owns 4,403 shares of the company’s stock worth $246,000 after buying an additional 133 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Medidata Solutions by 5.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,498 shares of the company’s stock worth $164,000 after buying an additional 177 shares in the last quarter. LS Investment Advisors LLC boosted its stake in Medidata Solutions by 9.2% in the second quarter. LS Investment Advisors LLC now owns 2,411 shares of the company’s stock worth $113,000 after buying an additional 203 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in Medidata Solutions by 1.8% in the third quarter. Municipal Employees Retirement System of Michigan now owns 12,720 shares of the company’s stock worth $709,000 after buying an additional 220 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Medidata Solutions by 13.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,978 shares of the company’s stock worth $110,000 after buying an additional 227 shares in the last quarter. Institutional investors own 99.63% of the company’s stock.
Medidata Solutions Company Profile